Skip to main content
SpringerLink
Log in

Diffuse intrahepatic recurrence after percutaneous radiofrequency ablation for solitary and small hepatocellular carcinoma

  • Case Report
  • Published:
Hepatology International Aims and scope Submit manuscript

Abstract

Two patients developed segmental, diffuse intrahepatic recurrence after percutaneous radiofrequency ablation (RFA) to treat a primary, solitary, and small (2.5 cm) hepatocellular carcinoma (HCC). Despite the size of the HCC, levels of the tumor markers (α-fetoprotein, α-fetoprotein-L3%, and des-γ-carboxyprothrombin) were all elevated before RFA, and tumors in both patients were contiguous with a major branch of the portal vein. Tumor biopsies of both patients revealed moderately differentiated HCC but diagnostic imaging showed an area of reduced tumor blood flow, suggesting a poorly differentiated component. Since early detection of post-RFA malignancies by standard ultrasonography and contrast-enhanced computed tomography was difficult, the most sensitive indicator of recurrence in these two patients was the elevated tumor markers. The diffuse intrahepatic recurrence was thought to be caused by increased intratumoral pressure during RFA, resulting in the dissemination of cancer cells through the contiguous portal vein. The clinical course of these tumors indicate that the choice of RFA should be carefully considered when treating specific subtype of HCC that is adjacent to main portal vein branch and involves a possible poorly differentiated component and that surgical resection or combinations of RFA with other treatment modalities such as transcatheter arterial chemoembolization should be considered as alternative treatment strategies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Rossi S, Di Stasi M, Buscarini E, Quaretti P, Garbagnati F, Squassante L, et al. Percutaneous RF interstitial ablation in the treatment of hepatic cancer. AJR Am J Roentgenol 1996;167:759–768

    PubMed  CAS  Google Scholar 

  2. Goldberg SN, Gazelle GS, Compton CC, Mueller PR, Tanabe KK. Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic–pathologic correlation. Cancer 2000;88:2452–2463. doi:10.1002/1097-0142(20000601)88:11<2452::AID-CNCR5>3.0.CO;2-3

    Article  PubMed  CAS  Google Scholar 

  3. Tateishi R, Shiina S, Teratani T, Obi S, Sato S, Koike Y, et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 2005;103:1201–1209. doi:10.1002/cncr.20892

    Article  PubMed  Google Scholar 

  4. Arii S, Yamaoka Y, Futagawa S, Inoue K, Kobayashi K, Kojiro M, et al. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nation-wide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology 2000;32:1224–1229. doi:10.1053/jhep.2000.20456

    Article  PubMed  CAS  Google Scholar 

  5. Llovet JM, Vilana R, Brú C, Bianchi L, Salmeron JM, Boix L, et al. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 2001;33:1124–1129. doi:10.1053/jhep.2001.24233

    Article  PubMed  CAS  Google Scholar 

  6. Takada Y, Kurata M, Ohkohchi N. Rapid and aggressive recurrence accompanied by portal tumor thrombus after radiofrequency ablation for hepatocellular carcinoma. Int J Clin Oncol 2003;8:332–335. doi:10.1007/s10147-003-0328-6

    Article  PubMed  Google Scholar 

  7. Seki T, Tamai T, Ikeda K, Imamura M, Nishimura A, Yamashiki N, et al. Rapid progression of hepatocellular carcinoma after transcatheter arterial chemoembolization and percutaneous radiofrequency ablation in the primary tumour region. Eur J Gastroenterol Hepatol 2001;13:291–294. doi:10.1097/00042737-200103000-00014

    Article  PubMed  CAS  Google Scholar 

  8. Portolani N, Tiberio GA, Ronconi M, Coniglio A, Ghidoni S, Gaverini G, et al. Aggressive recurrence after radiofrequency ablation of liver neoplasms. Hepatogastroenterology 2003;50:2179–2184

    PubMed  Google Scholar 

  9. Nicoli N, Casaril A, Hilal MA, Coniglio A, Ghidoni S, Gaverini G, et al. A case of rapid intrahepatic dissemination of hepatocellular carcinoma after radiofrequency thermal ablation. Am J Surg 2004;188:165–167. doi:10.1016/j.amjsurg.2003.12.061

    Article  PubMed  Google Scholar 

  10. Ruzzenente A, Manzoni GD, Molfetta M, Pachera S, Genco B, Donataccio M, et al. Rapid progression of hepatocellular carcinoma after radiofrequency ablation. World J Gastroenterol 2004;10:1137–1140

    PubMed  Google Scholar 

  11. Tamaki K, Shimizu I, Oshio A, Fukuno H, Inoue H, Tsutsui A, et al. Influence of large intrahepatic blood vessels on the gross and histological characteristics of lesions produced by radiofrequency ablation in a pig liver model. Liver Int 2004;24:696–701. doi:10.1111/j.1478-3231.2004.0952.x

    Article  PubMed  Google Scholar 

  12. Honda H, Tajima T, Kajiyama K, Kuroiwa T, Yoshimitsu K, Irie H, et al. Vascular changes in hepatocellular carcinoma: correlation of radiologic and pathologic findings. AJR Am J Roentgenol 1999;173:1213–1217

    PubMed  CAS  Google Scholar 

  13. Asayama Y, Yoshimitsu K, Irie H, Nishihara Y, Aishima S, Tajima T, et al. Poorly versus moderately differentiated hepatocellular carcinoma: vascularity assessment by computed tomographic hepatic angiography in correlation with histologically counted number of unpaired arteries. J Comput Assist Tomogr 2007;31:188–192. doi:10.1097/01.rct.0000236417.82395.57

    Article  PubMed  Google Scholar 

  14. Hagiwara S, Kudo M, Kawasaki T, Nagashima M, Minami Y, Chung H, et al. Prognostic factors for portal venous invasion in patients with hepatocellular carcinoma. J Gastroenterol 2006;41:1214–1219. doi:10.1007/s00535-006-1950-7

    Article  PubMed  Google Scholar 

  15. Carr BI, Kanke F, Wise M, Satomura S. Clinical evaluation of lens culinaris agglutinin-reactive alphafetoprotein and des-gamma-carboxyprothrombin in histologically proven hepatocellular carcinoma in United States. Dig Dis Sci 2007;52:776–782. doi:10.1007/s10620-006-9541-2

    Article  PubMed  CAS  Google Scholar 

  16. Yoshida S, Kurokohchi K, Arima K, Masaki T, Hosomi N, Funaki T, et al. Clinical significance of lens culinaris agglutinin-reactive fraction of serum alpha-fetoprotein in patients with hepatocellular carcinoma. Int J Oncol 2002;20:305–309

    PubMed  CAS  Google Scholar 

  17. Okuda H, Nakanishi T, Takatsu K, Saito A, Hayashi N, Yamamoto M, et al. Clinicopathologic features of patients with hepatocellular carcinoma seropositive for alpha-fetoprotein-L3 and seronegative for des-gamma-carboxy prothrombin in comparison with those seropositive for des-gamma-carboxy prothrombin alone. J Gastroenterol Hepatol 2002;17:772–778. doi:10.1046/j.1440-1746.2002.02806.x

    Article  PubMed  CAS  Google Scholar 

  18. Kotoh K, Morizono S, Kohjima M, Enjoji M, Sakai H, Nakamuta M. Evaluation of liver parenchymal pressure and portal endothelium damage during radio frequency ablation in an in vivo porcine model. Liver Int 2005;25:1217–1223. doi:10.1111/j.1478-3231.2005.01167.x

    Article  PubMed  Google Scholar 

  19. Kashiwagi K, Furusyo N, Kubo N, Nakashima H, Nomura H, Kashiwagi S, et al. A prospective comparison of the effect of interferon-alpha and interferon-beta treatment in patients with chronic hepatitis C on the incidence of hepatocellular carcinoma development. J Infect Chemother 2003;9:333–340. doi:10.1007/s10156-003-0271-5

    Article  PubMed  CAS  Google Scholar 

  20. Mazzella G, Accogli E, Scottili S, Festi D, Orsini M, Salzetta A, et al. Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis. J Hepatol 1996;24:141–147. doi:10.1016/S0168-8278(96)80022-5

    Article  PubMed  CAS  Google Scholar 

  21. Nishiguchi S, Kuroki T, Nakatani S, Morimoto H, Takeda T, Nakajima S, et al. Randomised trial of effects of interferon-a on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet 1995;346:1051–1055. doi:10.1016/S0140-6736(95)91739-X

    Article  PubMed  CAS  Google Scholar 

  22. Kubo S, Nishiguchi S, Hirohashi K, Tanaka H, Shuto T, Yamazaki O, et al. Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial. Ann Intern Med 2001;134:963–967

    PubMed  CAS  Google Scholar 

  23. Ikeda K, Arase Y, Saitoh S, Kobayashi M, Suzuki Y, Suzuki F, et al. Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor—a prospective randomized study of hepatitis C virus-related liver cancer. Hepatology 2000;32:228–232

    Article  PubMed  CAS  Google Scholar 

  24. Saborido BP, Díaz JC, de Los Galanes SJ, Segurola CL, de Usera MA, Garrido MD, et al. Does preoperative fine needle aspiration-biopsy produce tumor recurrence in patients following liver transplantation for hepatocellular carcinoma? Transplant Proc 2005;37:3874–3877. doi:10.1016/j.transproceed.2005.09.169

    Article  PubMed  Google Scholar 

  25. Stigliano R, Marelli L, Yu D, Davies N, Patch D, Burroughs AK. Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC. Cancer Treat Rev 2007;33:437–447. doi:10.1016/j.ctrv.2007.04.001

    Article  PubMed  CAS  Google Scholar 

  26. Seo S, Hatano E, Higashi T, Hara T, Tada M, Tamaki N, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography predicts tumor differentiation, P-glycoprotein expression, and outcome after resection in hepatocellular carcinoma. Clin Cancer Res 2007;13:423–433. doi:10.1158/1078-0432.CCR-06-1357

    Article  Google Scholar 

  27. Imai Y, Murakami T, Yoshida S, Nishikawa M, Ohsawa M, Tokunaga K, et al. Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading. Hepatology 2000;32:205–212. doi:10.1053/jhep.2000.9113

    Article  PubMed  CAS  Google Scholar 

  28. Asahina Y, Izumi N, Uchihara M, Noguchi O, Ueda K, Inoue K, et al. Assessment of Kupffer cells by ferumoxides-enhanced MR imaging is beneficial for diagnosis of hepatocellular carcinoma: comparison of pathological diagnosis and perfusion patterns assessed by CT hepatic arteriography and CT arterioportography. Hepatol Res 2003;27:196–204. doi:10.1016/S1386-6346(03)00261-4

    Article  PubMed  Google Scholar 

  29. Huppertz A, Haraida S, Kraus A, Zech CJ, Scheidler J, Breuer J, et al. Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT—initial observations. Radiology 2005;234:468–478. doi:10.1148/radiol.2342040278

    Article  PubMed  Google Scholar 

  30. Halavaara J, Breuer J, Ayuso C, Balzer T, Bellin MF, Blomqvist L, et al. Liver tumor characterization: comparison between liver-specific gadoxetic acid disodium-enhanced MRI and biphasic CT—a multicenter trial. J Comput Assist Tomogr 2006;30:345–354. doi:10.1097/00004728-200605000-00001

    Article  PubMed  Google Scholar 

  31. Sheen IS, Jeng KS, Shih SC, Wang PC, Chang WH, Wang HY, et al. Does surgical resection of hepatocellular carcinoma accelerate cancer dissemination? World J Gastroenterol 2004;10:31–36

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Second Department of Internal Medicine, Wakayama Medical University, 811-1 Kimiidera, Wakayama, 641-0012, Japan

    Yoshiyuki Mori, Hideyuki Tamai, Naoki Shingaki, Kosaku Moribata, Tatsuya Shiraki, Hisanobu Deguchi, Kazuki Ueda, Shotaro Enomoto, Hiroto Magari, Izumi Inoue, Takao Maekita, Mikitaka Iguchi, Kimihiko Yanaoka, Masashi Oka & Masao Ichinose

Authors
  1. Yoshiyuki Mori
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hideyuki Tamai
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Naoki Shingaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kosaku Moribata
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tatsuya Shiraki
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hisanobu Deguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kazuki Ueda
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Shotaro Enomoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Hiroto Magari
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Izumi Inoue
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Takao Maekita
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Mikitaka Iguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Kimihiko Yanaoka
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Masashi Oka
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Masao Ichinose
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hideyuki Tamai.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mori, Y., Tamai, H., Shingaki, N. et al. Diffuse intrahepatic recurrence after percutaneous radiofrequency ablation for solitary and small hepatocellular carcinoma. Hepatol Int 3, 509–515 (2009). https://doi.org/10.1007/s12072-009-9131-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12072-009-9131-4

Keywords

Search

Navigation